|
| Status |
Public on Apr 25, 2023 |
| Title |
205291550023_R01C02 |
| Sample type |
genomic |
| |
|
| Source name |
mice treated with guadecitabine/anti-PD-1
|
| Organism |
Mus musculus |
| Characteristics |
tissue: melanoma
sample id: SP13
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
genomic DNA was extracted and purified from mice samples using Qiagen DNeasy Kit according to standard instructions
|
| Label |
Cy5 and Cy3
|
| Label protocol |
Standard Illumina Protocol
|
| |
|
| Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium MouseMethylation array (MouseMethylation-12v1-0_A2) BeadChip using standard Illumina protocol
|
| Scan protocol |
Arrays were imaged using the HiScan SQ platform using standard recommended Illumina scanner setting
|
| Description |
Genomic DNA from Mice
205291550023_R01C02_Grn.idat
205291550023_R01C02_Red.idat
|
| Data processing |
Genome Studio v1 Software
|
| |
|
| Submission date |
Dec 12, 2022 |
| Last update date |
Apr 25, 2023 |
| Contact name |
Fabio Sallustio |
| E-mail(s) |
f.sallustio@nephro.uniba.it
|
| Organization name |
University of Bari
|
| Street address |
Piazza G. Cesare N°11
|
| City |
Bari |
| State/province |
Bari |
| ZIP/Postal code |
70124 |
| Country |
Italy |
| |
|
| Platform ID |
GPL32685 |
| Series (1) |
| GSE220698 |
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling the responses of T-cells, myeloid derived suppressor cells and NK cells |
|
